Keiichi Tamai

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Ikuro Sato · 5 shared papers, 2015–2025 · strength 0.57
   • Paper Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort S… DOI 10.3390/cancers17122006↗
   • Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315↗
   • Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
2. Makoto Abue · 4 shared papers, 2015–2025 · strength 0.46
   • Paper Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort S… DOI 10.3390/cancers17122006↗
   • Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
   • Paper Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production… DOI 10.3892/ijo.2018.4258↗
3. Kennichi Satoh · 3 shared papers, 2015–2022 · strength 0.24
   • Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315↗
   • Paper Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production… DOI 10.3892/ijo.2018.4258↗
   • Paper Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. DOI 10.3892/ijo.2014.2743↗
4. Kensuke Ota · 1 shared paper, 2025 · strength 0.24
   • Paper Repeated COVID-19 Vaccination as a Poor Prognostic Factor in Pancreatic Cancer: A Retrospective, Single-Center Cohort S… DOI 10.3390/cancers17122006↗
5. Kazuo Sugamura · 2 shared papers, 2015–2020 · strength 0.14
   • Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
   • Paper Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. DOI 10.3892/ijo.2014.2743↗
6. Misa Yokoyama · 2 shared papers, 2015–2018 · strength 0.12
   • Paper Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production… DOI 10.3892/ijo.2018.4258↗
   • Paper Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. DOI 10.3892/ijo.2014.2743↗
7. Hiroyuki Kato · 1 shared paper, 2022 · strength 0.12
   • Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315↗
8. Keiichi Jingu · 1 shared paper, 2022 · strength 0.12
   • Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315↗
9. Katsuya Fukui · 1 shared paper, 2022 · strength 0.12
   • Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315↗
10. Hiroshi Shima · 1 shared paper, 2022 · strength 0.12
    • Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315↗
11. Toru Furukawa · 1 shared paper, 2022 · strength 0.12
    • Paper PP6 deficiency in mice with KRAS mutation and Trp53 loss promotes early death by PDAC with cachexia-like features. DOI 10.1111/cas.15315↗
12. Yuuri Hatsuzawa · 1 shared paper, 2020 · strength 0.10
    • Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
13. Masamichi Mizuma · 1 shared paper, 2020 · strength 0.10
    • Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
14. Michiaki Unno · 1 shared paper, 2020 · strength 0.10
    • Paper CD109 promotes the tumorigenic ability and metastatic motility of pancreatic ductal adenocarcinoma cells. DOI 10.1016/j.pan.2020.01.013↗
15. Shin Hamada · 1 shared paper, 2015 · strength 0.05
    • Paper Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. DOI 10.3892/ijo.2014.2743↗
16. Tooru Shimosegawa · 1 shared paper, 2015 · strength 0.05
    • Paper Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. DOI 10.3892/ijo.2014.2743↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.